Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort

Morbidity and mortality in thalassemia are associated with iron burden. Recent advances in organ-specific iron imaging and the availability of oral deferasirox are expected to improve clinical care, but the extent of use of these resources and current chelation practices have not been well described...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kwiatkowski, Janet L., Kim, Hae-Young, Thompson, Alexis A., Quinn, Charles T., Mueller, Brigitta U., Odame, Isaac, Giardina, Patricia J., Vichinsky, Elliott P., Boudreaux, Jeanne M., Cohen, Alan R., Porter, John B., Coates, Thomas, Olivieri, Nancy F., Neufeld, Ellis J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2012
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3327453/
https://ncbi.nlm.nih.gov/pubmed/22279056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-04-344507
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak